Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer (Q73516937)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Addition of cisplatin improves efficacy of 131I-labeled monoclonal antibody 323/A3 in experimental human ovarian cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

1 reference

E Kievit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H M Pinedo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H M Schlüper

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

E Boven

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

419-428

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

The effect of cisplatin on the repair of radiation damage in RIF1 mouse tumours in vivo

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

WiDr is a derivative of another colon adenocarcinoma cell line, HT-29.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Radiation and chemotherapy sensitizers and protectors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Single-dose intraperitoneal radioimmunotherapy with the murine monoclonal antibody I-131 MOv18: Clinical results in patients with minimal residual disease of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

SCLC-cluster-2 antibodies detect the pancarcinoma/epithelial glycoprotein EGP-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Comparison of 131I-labelled anti-episialin 139H2 with cisplatin, cyclophosphamide or external-beam radiation for anti-tumor efficacy in human ovarian cancer xenografts.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Continuous infusion chemotherapy as a radiation-enhancing agent for yttrium-90-radiolabeled monoclonal antibody therapy of a human tumor xenograft

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2897%2982501-1

7 January 2021

10.1016/S0360-3016(97)82501-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9226331%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference